We have located links that may give you full text access.
[Inhaled nitric oxide in the therapy of acute hypoxemic respiratory failure of newborn].
Medycyna Wieku Rozwojowego 2001 October
AIM: To determine the efficiency of inhaled nitric oxide(INO) in term and preterm newborns with acute hypoxemic respiratory failure(AHRF), influence of this therapy on the systemic circulation and efficiency of the therapy in relation to the applied ventilation (conventional or oscillatory (HFOV)).
METHODS: Term and preterm ventilated newborns with acute hypoxemic respiratory failure with oxygenation index(OI) >/= 15 were included. The mode of ventilation was not changed before initiation and was continued during INO therapy. Starting dose of INO was 20 parts per million (ppm) and during the last two years it was 1 Oppm. Heart rate, arterial blood pressure, methaemoglobin level, diuresis (in urinary catheterized newborns) were monitored. The efficiency of INO was determined on the ground of 20% decrease of 01.
RESULTS: Investigations were performed in 43 term and premature newborns. After initiation of INO there was a statistically significant fall of 01. Therapy was effective in 72.1 % patients. There was no influence of the therapy on the systemic circulation heart rate and medial artery pressure were statistically unchanged. In 16 catheterized newborns statistically essential increase of diuresis was observed. This effect was more distinct in patients in whom INO therapy was effective. INO therapy was more effective in newborns with respiratory distress syndrome, congenital infection and adult respiratory distress syndrome and less effective in newborns with respiratory distress syndrome with congenital infection and meconium aspiration syndrome. There were no essential differences in efficiency of INO between patients ventilated conventionally and oscillatory.
CONCLUSIONS: INO improves oxygenation in term and preterm newborns with AHRF. INO does not cause depression of the systemic circulation. The increase of diuresis after initiation of INO seems to be associated with improving of oxygenation of the patients. This observation needs to be confirmed by subsequent investigations. The efficacy of INO therapy depends on the cause of hypoxemic respiratory failure. The synergistic effect of INO and HFOV was not confirmed.
METHODS: Term and preterm ventilated newborns with acute hypoxemic respiratory failure with oxygenation index(OI) >/= 15 were included. The mode of ventilation was not changed before initiation and was continued during INO therapy. Starting dose of INO was 20 parts per million (ppm) and during the last two years it was 1 Oppm. Heart rate, arterial blood pressure, methaemoglobin level, diuresis (in urinary catheterized newborns) were monitored. The efficiency of INO was determined on the ground of 20% decrease of 01.
RESULTS: Investigations were performed in 43 term and premature newborns. After initiation of INO there was a statistically significant fall of 01. Therapy was effective in 72.1 % patients. There was no influence of the therapy on the systemic circulation heart rate and medial artery pressure were statistically unchanged. In 16 catheterized newborns statistically essential increase of diuresis was observed. This effect was more distinct in patients in whom INO therapy was effective. INO therapy was more effective in newborns with respiratory distress syndrome, congenital infection and adult respiratory distress syndrome and less effective in newborns with respiratory distress syndrome with congenital infection and meconium aspiration syndrome. There were no essential differences in efficiency of INO between patients ventilated conventionally and oscillatory.
CONCLUSIONS: INO improves oxygenation in term and preterm newborns with AHRF. INO does not cause depression of the systemic circulation. The increase of diuresis after initiation of INO seems to be associated with improving of oxygenation of the patients. This observation needs to be confirmed by subsequent investigations. The efficacy of INO therapy depends on the cause of hypoxemic respiratory failure. The synergistic effect of INO and HFOV was not confirmed.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app